Postchemotherapy ejaculatory azoospermia: Fatherhood with sperm from testis tissue with intracytoplasmic sperm injection

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 930-936

  Damani, M N ^a   Masters, V ^a   Meng, M V ^a   Burgess, C ^a   Turek, P ^a   Oates, R D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; IFOSFAMIDE; LOMUSTINE; PROCARBAZINE;

ADULT; ARTICLE; AZOOSPERMIA; CANCER CHEMOTHERAPY; CELL MATURATION; CLINICAL ARTICLE; CRYOPRESERVATION; DRUG CYTOTOXICITY; EJACULATION; HISTOPATHOLOGY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MALE; MALE FERTILITY; MALE INFERTILITY; OBSTRUCTIVE UROPATHY; OUTCOMES RESEARCH; PATERNITY; PRIORITY JOURNAL; SEMEN ANALYSIS; SERTOLI CELL; SPERMATOGENESIS; TESTICULAR SPERM EXTRACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; GERMINOMA; HUMANS; INFANT; MALE; OLIGOSPERMIA; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; SPERMATOZOA; TESTICULAR NEOPLASMS; TESTIS; TREATMENT OUTCOME;

EID: 0037083408     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.930     Document Type: Article

References (45)

1. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996
2. Effects of cancer chemotherapy on gonadal function and reproductive capacity
3. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma
4. Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer
5. Male fertility in long-term survivors of childhood ALL
6. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease
7. Do men undergoing sterilizing cancer treatments have a fertile future?
8. Cancer and male factor infertility
9. Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
10. Distribution of spermatogenesis in the testicles of azoospermic men: The presence or absence of spermatids in the testes of men with germinal failure
11. Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia
12. Testicular sperm extraction and intracytoplasmic sperm injection: A chance of fertility in nonobstructive azoospermia
13. TESE and the distribution of spermatogenesis in the testicles of azoospermic men
14. Outcome of testicular sperm retrieval procedures in non-obstructive azoospermia: Percutaneous aspiration versus open biopsy
15. In vitro fertilization outcomes after intracytoplasmic sperm injection with fresh or frozenthawed testicular spermatozoa
16. Fertilization, pregnancy and embryo implantation rates after ICSI with fresh or frozen-thawed testicular spermatozoa
17. Testicular sperm extraction for nonobstructive azoospermia: Results of a multibiopsy approach with optimized tissue dispersion
18. Presence of mature sperm in testicular parenchyma of men with nonobstructive azoospermia: Prevalence and predictive factors
19. Electroejaculation before chemotherapy in adolescents and young men with cancer
20. Fertilization and pregnancy using intentionally cryopreserved testicular tissue as the sperm source for intracytoplasmic sperm injection in 10 men with non-obstructive azoospermia
21. Systemic fine-needle aspiration of the testis correlation to biopsy and results of organ "mapping" for mature sperm in azoospermic men
22. Diagnostic findings from testis fine needle aspiration mapping in obstructed and nonobstructed azoospermic men
23. Testis sperm extraction and intracytoplasmic sperm injection guided by prior fine-needle aspiration mapping in patients with nonobstructive azoospermia
24. Techniques of aspiration and smear preparation
25. Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy
26. Gonadal damage from chemotherapy and radiotherapy
27. Dose-dependent impairment of testicular function in patients treated with cisplatinbased chemotherapy for germ cell cancer
28. Gonadal and sexual function in men treated for childhood cancer
29. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood
30. Male gonadal function after chemotherapy in survivors of childhood malignancy
31. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin
32. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas
33. Gonadal function in men with testicular cancer: Biological and clinical aspects
34. Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
35. Persistent altered spermatogenesis in long-term childhood cancer survivors
36. Male reproductive potential after MOPP therapy for Hodgkin's disease: A long-term survey
37. Gonadal function following ABVD therapy for Hodgkin's disease
38. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas
39. Fertility after chemotherapy for testicular germ cell cancer
40. Vincristine is associated with the risk of azoospermia in adult male survivors of childhood malignancies
41. Birth after treatment of a male with seminoma and azoospermia with cryopreserved-thawed testicular tissue
42. Birth defects and childhood cancer in offspring of survivors of childhood cancer
43. Offspring of patients treated for cancer in childhood
44. Cancer in offspring of long-term survivors of childhood and adolescent cancer
45. Children fathered by men treated with chemotherapy for testicular cancer